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Management
Abstract

Background
Self-care management in heart failure (HF) involves decision-making to evaluate, and actions to
ameliorate symptoms when they occur. This study sought to compare the risks of all-cause mortality,
hospitalization, or emergency-room admission among HF patients who practice above-average self-care
management, those who practice below-average self-care management, and those who are symptomfree.

Methods
A secondary analysis was conducted of data collected on 195 HF patients. A Cox proportional hazards
model was used to examine the association between self-care management and event risk.

Results
The sample consisted of older (mean ± standard deviation = 61.3 ± 11 years), predominantly male (64.6%)
adults, with an ejection fraction of 34.7% ± 15.3%; 60.1% fell within New York Heart Association class III or
IV HF. During an average follow-up of 364 ± 288 days, 4 deaths, 82 hospitalizations, and 5 emergencyroom visits occurred as first events. Controlling for 15 common confounders, those who engaged in
above-average self-care management (hazard ratio, .44; 95% confidence interval, .22 to .88; P < .05) and
those who were symptom-free (hazard ratio, 0.48; 95% confidence interval, .24 to .97; P < .05) ran a lower
risk of an event during follow-up than those engaged in below-average self-care management.

Conclusion
Symptomatic HF patients who practice above-average self-care management have an event-free survival
benefit similar to that of symptom-free HF patients.
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Abstract
Background—Self-care management in heart failure (HF) involves decision-making to evaluate,
and actions to ameliorate symptoms when they occur. The purpose of this study was to compare
the risk of all-cause mortality, hospitalization or emergency room admission among HF patients
who practice above average self-care management, those who practice below average self-care
management, and those who are symptom-free.
Methods—A secondary analysis was completed of data collected on 195 HF patients. A Cox
proportional hazards model was used to examine the association between self-care management
and event risk.
Results—The sample was in older adulthood (61.3±11 years), predominantly male (64.6%), with
an ejection fraction of 34.7%±15.3%; 60.1% had New York Heart Association class III or IV HF.
During an average follow-up period of 364±288 days, there were 4 deaths, 82 hospitalizations, and
5 emergency room visits as first events. Controlling for fifteen common confounders, those who
engaged in above average self-care management (HR, 0.44; 95% CI, 0.22-0.88; P<.05) and those
who were symptom-free (HR, 0.48; 95% CI, 0.24-0.97; P<.05) had a lower risk of an event during
follow-up, than those engaged in below average self-care management.
Conclusion—Symptomatic HF patients who practice above average self-care management have
an event-free survival benefit similar to that of symptom-free HF patients.

Introduction
Heart failure (HF) is a common endpoint of highly prevalent cardiovascular disorders.1 Both
the one-year mortality rate2 and composite risk of death or re-hospitalization within one
year after discharge from a HF hospitalization3 remain substantial despite advances in the
medical care of patients with HF. It has been suggested that more than 50% of
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hospitalizations for HF,4 and ostensibly a proportion of HF deaths are preventable.
Moreover, strategies for managing HF that have additional benefit over optimal medical
care, such as enhancing self-care, have been presented as being critical to improving health
outcomes in this population.5, 6
HF self-care is a naturalistic decision-making process involving patient behaviors that help
maintain physiologic homeostasis and prevent exacerbations.7 These daily routine
behaviors, referred to as self-care maintenance or adherence behaviors, reflect the degree to
which a patient follows healthcare providers' recommendations.8 Importantly, HF self-care
also involves active patient decision-making to evaluate and actions that effectively
ameliorate HF symptoms when they occur.9 These behaviors, referred to as self-care
management behaviors, are triggered by symptoms, which not all HF patients experience
routinely. Although it is assumed that effective HF self-care management helps optimize
health outcomes, relatively little is known about the effectiveness of self-care management
behaviors in this population.
Accordingly, the purpose of this analysis was to describe the significance of HF self-care
management in estimating risk of all-cause mortality, hospitalization or emergency room
admission. First, we examined and described group differences in bio-behavioral
characteristics among persons with HF who are symptom-free, persons who are engaged in
below average HF self-care management, and persons who are engaged in above average
HF self-care management. Second, under the hypothesis that self-care management would
help explain event-risk, we described risk of all-cause mortality, hospitalization or
emergency room admission among persons who were symptom-free, those engaged in
below average HF self-care management, and those engaged in above average HF self-care
management.

Methods
To test our hypothesis, we completed a secondary analysis of merged data collected on 195
HF patients as part of three parent studies10, 11 conducted by a team of HF investigators
from 2004-2007. Measures of HF self-care and clinical event data were available on all 195
subjects included in this analysis. All parent study protocols were reviewed and approved by
an appropriate institutional review board at each participating center, and written informed
consent was obtained from all study participants. Patients were recruited from academic
medical centers in East South Central, and South Atlantic regions of the United States.
Measurement
Patient Characteristics—Baseline demographic, clinical and self-care data included in
this secondary analysis were collected at enrollment during each of the parent studies.
Patient characteristics of age, gender, and ethnicity were collected using patient interview
and medical record review. Height and weight were measured using a stadiometer and beam
scale respectively. Comorbid conditions were assessed with the widely used 17-item
Charlson Comorbidity Index.12 A list of 17 comorbid diseases was evaluated with the
possible score ranging from 0 to 30. All participants had a score of at least 1 because all had
HF; scores of 1 or 2 indicate low risk, scores of 3 or 4 indicate medium risk, and scores of 5
or more indicate high risk. Depressive symptoms were assessed using Beck Depression
Inventory II (BDI).13 Higher values of the BDI indicate a greater level of depressive
symptoms. BDI scores ranging from 0-13, 14-19, 20-28, and 29-63 indicate minimal, mild,
moderate and severe depressive symptoms respectively.
Illness and Treatment Characteristics—HF etiology, left ventricular ejection fraction
(LVEF), and prescribed HF medications were assessed through a review of the medical
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record. NYHA functional classification was assessed by clinicians and identified through
medical record review. Subjective functional capacity was assessed using the Duke Activity
Status Index (DASI),14 a 12-item self-reported scale that assesses the level of difficulty
experienced in completing physical tasks. Higher scores (range 0 to 58.2) on the DASI
indicate greater functional capacity. Health-related quality of life was measured using the
Minnesota Living with Heart Failure Questionnaire (MLHFQ).15 Higher scores (range 0 to
105) on the MLHFQ indicate worse HF health-related quality of life.
Measures of Self-Care Maintenance and Confidence—Self-care maintenance was
measured using the Medical Outcomes Study specific adherence scale (MOS) score. The
MOS consists of nine self-rated questions that capture adherence to routine daily practices of
exercise, taking HF medications as prescribed, maintaining alcohol, tobacco and dietary
restrictions, as well as daily weight measurement and symptom monitoring. Higher scores
on the MOS indicate better adherence to prescribed therapy. Self-care maintenance was also
measured at enrollment with the Self-Care of Heart Failure Index (SCHFI).7 The SCHFI
contains 15 items measured on a four-point Likert scale, which form three scales: a) selfcare maintenance, b) self-care management, and c) self-care confidence. Items measuring
self-care maintenance capture adherence to routine daily practices of weight maintenance
and measurement, symptom monitoring, dietary restriction, and physical activity. The selfcare confidence subscale captures patients' perceived ability to engage in self-care behaviors
(keep free from HF symptoms, follow treatment advice, evaluate the importance of HF
symptoms etc.). Scores on each of the SCHFI scales range from 0-100, with higher scores
indicating better self-care.
Self-Care Management—Self-care management, the focus of this research, also was
assessed at enrollment using the SCHFI. Self-care management items (Table 1) capture HF
symptom evaluation, likelihood of self-initiated symptom management strategies, and
evaluation of treatment effectiveness. Scores on the SCHFI self-care management scale also
range from 0-100, with higher scores indicating better self-care management. Self-care
management items of the SCHFI are only completed if the person with HF has experienced
symptoms in the preceding three months. Thus, patients who were symptom-free in the three
months preceding assessment did not fill out this section of the SCHFI and do not have a
SCHFI management scale score.
Statistical Analysis—Self-care management scores were transformed into the following
categories: patients who had HF symptoms but reported self-care management below the
sample arithmetic mean 63.63 (below average self-care management), patients who had
symptoms but reported self-care management above the sample arithmetic mean (above
average self-care management), and patients who did not have to engage in HF self-care
management as they were symptom-free (symptom-free).
Comparisons between persons with HF who were symptom-free, and persons who engaged
in HF self-care management were made using Student's t tests, Mann-Whitney U tests,
Fisher's exact tests, or Pearson χ2 analysis where appropriate. Comparisons among persons
with HF who were symptom-free, persons who engaged in below average HF self-care
management, and persons who engaged in above average HF self-care management were
made using analysis of variance, Kruskal-Wallis tests, or Pearson χ2 analysis where
appropriate. Results are expressed in mean ± standard deviation (SD) or proportions where
appropriate. Statistical significance was predetermined at P < .05.
Hierarchical Cox proportional hazards modeling was used in the analysis of risk of first
event, including all-cause mortality, hospitalization or emergency room admission as a
cumulative endpoint. Patient characteristics (age, gender, BMI calculated as (weight (lb)/
Heart Lung. Author manuscript; available in PMC 2012 January 1.
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[height (in)]2×703), BDI score, and Charlson Comorbidity Index score) were included in the
first block of the model. HF characteristics (HF etiology, LVEF, NYHA class, prescription
of an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker
(ARB), prescription of a β-adrenergic receptor blocker, MLHFQ score, and DASI score)
were included in the second block. Indices of self-care maintenance and confidence (MOS
score, and SCHFI maintenance and confidence scale scores) were included in the third block
of the model. To assess the additive influence self-care management, all three categories
(below average self-care management, above average self-care management, and symptomfree) were added in the final block of the model. The influence of each group of variables
was assessed by evaluating the statistical significance of the block and overall model χ2.
Hazard Ratios (HR) with 95% Confidence Intervals (CI) were calculated to determine the
influence of individual variables in explaining event-risk. Risk of near-extreme
multicolinearity was predetermined as a linear correlation of independent variable regression
coefficients greater than 0.8.16 Assuming alpha of 0.05 and preserving power of 0.80, data
on 195 patients allowed for the detection of minimal Cox proportional hazard ratios of 1.500
or 0.665. All analyses were performed using SPSS version 15.0 (Chicago, IL).

Results
Comparing data among the three parent studies on patients characteristics, HF
characteristics, and indices of self-care maintenance, management and confidence, the one
significant difference was the proportion of women enrolled (χ2=8.426, P=.015). As such,
gender was included in the event-risk model. The sample (Table 2) was predominantly male
(67.6%), in older adulthood (61±11 years), and the vast majority self-identified as being
Caucasian (79%). Average BMI was 32.2±7.7 kg/m2, and the sample had minimal
depressive symptoms (BDI=11.1±7.7). The typical participant had a moderate level of
comorbidity. The majority of subjects had ischemic HF (56.1%), most were in NYHA
function class II or III HF, were prescribed ACE inhibitors or ARBs (85%) and β-adrenergic
blockers, and had a moderately reduced LVEF. Most subjects were engaged in HF self-care
management, but about one-third were symptom-free in the three months preceding
enrollment.
Bio-behavioral Differences by Category of Self-Care Management
Persons engaged in above average self-care management were more likely to be female (P<.
05), have a greater BMI (P<.05), have more depressive symptoms (P<.001), higher NYHA
functional class (P<.001), poorer quality of life (P<.001), and worse subjective functional
capacity (P<.001), compared to those who were symptom-free and persons engaged in
below average self-care management (Table 2).
Self-Care Management and Event-Risk
Over the average follow-up period of 364±288 days, there were 4 deaths (2 HF deaths, 2
other deaths), 82 hospitalizations (15 for HF, 23 for other cardiac issues, 44 for non-cardiac
reasons), and 5 emergency room visits (2 for HF and 3 for other cardiac issues) as first
clinical events. The slight majority of subjects (n=104) completing enrollment in the parent
studies were event-free. In the Cox proportional hazards model there was no detectable risk
of near-extreme multicolinearity.
Sociodemographic and clinical patient characteristics (age, gender, BMI, BDI score, and
Charlson Comorbidity Index score) explained risk of an event during follow-up (χ2=23.31,
P<.001). HF-specific characteristics (HF etiology, LVEF, NYHA functional class,
prescription of an ACE inhibitor or ARB and/or β-adrenergic receptor blocker, MLHFQ
total score, and DASI score) added significantly to the model (Block χ2=18.84, P<.05;
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Model χ2=43.97, P<.001). Measures of self-care maintenance and confidence (MOS
adherence score, and SCHFI maintenance and confidence subscale scores) did not add to the
model (Block χ2=6.07, P=.11; Model χ2=50.05, P<.001). But, the three categories of selfcare management (below average self-care management, above average self-care
management, and symptom-free) added significantly to the model (Block χ2=6.72, P<.05;
Model χ2=55.69, P<.0001).
Individual factors associated significantly with risk of all-cause mortality, hospitalization or
emergency room admission in the full model (Table 3) were age (HR, 0.967; 95% CI,
0.941-0.995) BDI score (HR, 1.058; 95% CI, 1.019-1.099), prescription of a β-adrenergic
blocker (HR, 0.346; 95% CI, 0.187-0.641), and DASI score (HR, 0.960; 95% CI,
0.930-0.991). In addition, all categories of self-care management were significantly
associated with event risk during follow-up. Relative to persons reporting below average
self-care management scores, those with above average self-care management scores (HR,
0.441; 95% CI, 0.222-0.877; P < .05) and those who were symptom-free (HR, 0.481; 95%
CI, 0.238-0.971; P < .05) were less likely to have an event during follow-up (Figure 1).

Discussion
In this study, we found that persons more engaged in HF self-care management had a 56%
reduction (95% CI 12% to 78%) in the risk of all-cause mortality, hospitalization or
emergency room admission than persons who were less engaged, after taking into
consideration factors shown by others to be associated with these events. Second, persons
with HF who were more engaged in self-care management had a an event risk nearly
equivalent to those who were symptom-free, despite being a group that had more depressive
symptoms, more severe NYHA functional class, lower functional capacity, poorer qualityof-life, and less confidence in their abilities to engage in self-care. Moreover, in this study
the effect of HF self-care management on event-risk was close to the effect of having been
prescribed a β-adrenergic receptor blocker.
Self-Care Management and Event-Free Survival
To the best of our knowledge, this is the first evidence that subjective self-care management
(evaluation and self-treatment of HF symptoms) is associated with objective outcomes in
persons with HF. Approximately 90% of persons admitted with HF have signs of clinical
congestion,17 the early detection and treatment of which have been proposed as influencing
outcomes in persons with HF.18 Until now, however, there has been no empirical data to
support the hypothesis that effective HF self-care management (recognizing and treating
clinical congestion) improves all-cause event-free survival. In fact, self-care management is
rarely considered an important factor in models that determine risk of health outcomes in
this population. This evidence of the clinical importance of the decision-making inherent in
self-care management, however, suggests that patients who quickly recognize and act to
ameliorate HF symptoms can greatly improve their outcomes. Moreover, we have provided
preliminary evidence that patients who are better at self-care management may reduce their
risk of events that may or may not be related to HF.
HF patients who were symptomatic but more engaged in self-care management practices
had a risk of untoward events similar to that of symptom-free patients, even after adjusting
for patient and clinical factors that clinicians typically judge to be important, including
treatment adherence. Patient decision-making and actions of HF self-care management are
quite different than routine practices of treatment adherence. Although both our indices of
adherence were highest in persons who were more engaged in self-care management,
measures of adherence were not associated with event-free survival either individually or in
combination after adjustment for covariates. That is not to say that adherence to prescribed
Heart Lung. Author manuscript; available in PMC 2012 January 1.
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therapy is unimportant. Rather, we have identified modifiable self-care behaviors that have
an additional event-free survival benefit over HF treatment and treatment adherence.
Two systematic reviews provided preliminary evidence of a relationship between self-care
and risk of hospitalization in patients with HF. As part of a systematic review, McAlister
and colleagues19 reported that enrollment in interventional programs designed to enhance
HF patient self-care significantly reduced re-hospitalization for HF (RR 0.66) and all-cause
re-hospitalization (RR 0.73). Similarly, Jovicic and colleagues20 reported a significant
decrease in HF readmission (OR 0.44) and all-cause readmission (OR 0.59) in a separate
systematic review of self-care interventions. The interventions included in these reviews
never confirmed that self-care actually improved, however. Further, most interventions
focused only on self-care maintenance behaviors. Thus, despite the appeal of general
inferences that can be drawn from these reviews, they did not provided definitive evidence
for the direct relationship between self-care and health outcomes or for the importance of
self-care management, which were demonstrated in this study.
Several factors other than self-care were associated with risk of an event during follow-up in
this study. In our analysis, increasing age was associated with a small-but-significant
decrease in event-risk. This result differs from that previously reported by Rich21 Huynh22
and Goldberg23 and their respective colleagues, all of whom report an increased risk of
mortality and/or hospitalization with age in the HF population. In the Huynh22 and
Goldberg23 studies, the mean age was at least 15 years older than the mean age of our
sample, while Rich and colleagues21 categorized age to estimate risk of mortality and
hospitalization. These differences alone may explain why we did not detect the same
influence of age. Further, including such factors as depression, activity and functional
limitation, quality of life, and measures of self-care in our multivariate model may have
accounted for the influence of age found in prior studies.
In our study, incremental (every 1-point) increases in depressive symptoms added a 6%
increase in all-cause event-risk, consistent with the findings of other investigators. For
example, Junger and colleagues24 identified that depression increased the risk of mortality
by 8% (HR, 1.08; CI 1.01-1.15), although this effect was time-dependent, and Jiang and
colleagues25 reported a 2% increase in risk of mortality per every 1-point increase in BDI
score. Prescription of a β-adrenergic blocker reduced event risk in our analysis by 66%,
confirming results from large clinical trials,26-28 despite comparative differences in sample
age, LVEF and overall mortality rates. Better functional capacity was associated with a
small-but-significant decrease in event risk, consistent with results from Shaw and
colleagues.29 NYHA functional class was not a significant predictor of event risk, perhaps
because we used all-cause outcome measures not just those related to HF.
Comment on Bio-behavioral Differences
We found significant differences in bio-behavioral characteristics among groups of self-care
management. These results were largely confirmatory, adding to a growing body of
evidence that HF symptoms are related to gender,30 BMI,31 quality of life,32 depression,33
and functional capacity.34 While these and several other univariate differences in biobehavioral characteristics warrant further investigation, they are important to this study
primarily for one reason. That is, the influence of bio-behavioral factors, including self-care
maintenance and confidence, must be controlled in order to determine the relative
importance of self-care management as a predictor of event-free survival.
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Clinical Implications
Formally, there are many ways to measure self-care behaviors of patients with HF. In day to
day clinical practice, however, HF clinicians most commonly judge engagement in self-care
based on observation and patient self-report. In this paper, we have provided evidence that
HF patients who are more engaged in self-care management and those who are symptomfree are less than half as likely to have an event during follow-up, than patients who are less
engaged in self-care management as assessed by self-report. These findings are important to
clinical practice for two reasons. First, these data provide the preliminary base of evidence
to support the teaching and fostering self-care practices in this patient population.
Particularly, teaching HF patients the actions to take when symptoms occur, and evaluating
patients' skills in this regard during follow-up are important additions to routine HF patient
education. Second, these results serve as evidence to impress upon patients the vital role
they play in determining their own outcomes.

Strengths and Limitations
This was a secondary analysis of observational study data. As such, certain characteristics
including patient age and functional parameters may not resemble efficacy study or other HF
populations. Thus, inferences to a broad range of HF patients may be limited. Although we
attempted to control for confounding factors, other, unidentified factors could have
influenced the relationship between self-care management and event risk that were not
included in the analysis. In previous studies, age,22 gender,35 BMI,36 depressive symptoms,
25 comorbid conditions,37 LVEF,38 NYHA functional class,39 ischemic etiology,40
treatment with ACE inhibitors41 and β-blockers,26 quality of life,42 and activity limitations29
were identified as significant determinants of mortality or hospitalization in persons with
HF. Thus, a strength of our study was that we controlled the influence of these factors. In
addition to these important factors, we controlled for self-care maintenance and confidence,
both which varied among categories of self-care management. Although the use of Cox
proportional hazards modeling allows for the control of differing patient characteristics, we
did not account for potential time-dependent covariates that may be influential. Finally, only
significant associations and not causal mechanisms between self-care management and
event risk during follow-up can be described.

Conclusion
In summary, measures of HF self-care management had independent predictive value in the
determination of all-cause event-free survival after controlling for important clinical and
psychosocial factors including treatment adherence. Patients more engaged in self-care
management had less than half the risk of all-cause mortality, hospitalization or emergency
room admission than patients less engaged in self-care management. Further, those who
were more engaged in self-care management had an all-cause event risk nearly equivalent to
patients who were symptom-free, despite being a group that has a markedly worse biobehavioral risk profile. Future research that measures health outcomes in persons with HF
should include self-care management as a predictive factor. The relationship between selfcare management and HF-specific events in larger populations also warrants future research.
Further, interventions to enhance self-care management, not just self-care maintenance or
adherence, should be developed to improve outcomes in this population.
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Figure 1. Event-Free Survival: Cox Proportional Hazard Model

Cox proportional hazards model results show the difference in composite event-risk for
patients who were symptom-free, those who practiced above average self-care management,
and those who practiced below average self-care management. Results shown controlling for
age, gender, body mass index, Beck Depression Inventory II score, comorbid conditions, left
ventricular ejection fraction, heart failure etiology, New York Heart Association functional
class, prescription of ACE inhibitors or ARBs, and/or β-adrenergic blockers, Duke Activity
Status Index total score, Minnesota Living with Heart Failure Questionnaire total score,
Medical Outcomes Study specific adherence score, and Self-Care of Heart Failure Index
maintenance and confidence subscale scores.
Abbreviations: ACE = angiotensin converting enzyme, ARB = angiotensin receptor
antagonist, ER = emergency room, HR = adjusted hazard ratio.
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How sure were you that the remedy helped or did not help?

N/A

2

1

Not Sure

1

Think of a remedy you tried the last time you had trouble breathing or ankle swelling;

Call your doctor or nurse for guidance

2

1

2

Somewhat Sure

2

1

2

Somewhat Likely

2

Somewhat Quickly

Take an extra water pill

Not Likely

1

Not Quickly

Reduce your fluid intake

Not Applicable

0

I did not recognize it

1

N/A

Have not
had these

Yes or No

Reduce the salt in your diet

If you have trouble breathing or ankle swelling, how likely are you to try one of these
remedies?

How quickly did you recognize it as a symptom of heart failure?

In the past 3 months, have you had trouble breathing or ankle swelling?

Original Self-Care of Heart Failure Index self-care management items.

Self-Care of Heart Failure Index Management Subscale Questions

3

Sure

3

3

3

3

Likely

3

Quickly

4

Very Sure

4

4

4

4

Very Likely

4

Very Quickly
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Table 2

Sociodemographic and Clinical Characteristics of the Sample
“*”P<.05 between symptom free patients and those engaged in self-care management based on Fisher's exact
test, Mann-Whitney U test, Pearson χ2 test, or Student's t test where appropriate. “†”P<.05 among symptom
free, below average self-care management, and above average self-care management groups based on Pearson
χ2 test, Kruskal-Wallis test, or analysis of variance where appropriate. Abbreviations: ACE = angiotensin
converting enzyme, ARB = angiotensin receptor blocker, MLHFQ = Minnesota Living with Heart Failure
Questionnaire, MOS = Medical Outcome Study, SC = Self-Care, S-CHFI = Self-Care of Heart Failure Index,
SD = standard deviation.
Category of Self-Care Management

Variables
Age
Gender (% female)

Total
n=195

Symptom Free
n=65

Below Average
n=70

Above Average
n=60

Mean±SD or %

Mean±SD or %

Mean±SD or %

Mean±SD or %

61.31 ±11.05

63.3±10.4

60.6±10.7

60.0±11.8

35.4

24.6*

34.3

48.3†

79

83.1

80

75

18.9

15.4

18.6

23.3

Ethnicity
Caucasian
African American

2.1

1.5

1.4

1.7

Body Mass Index

Other

32.15±7.66

30.3±7.8*

32.4±7.2

33.9±8.5†

Beck Depression Inventory II

11.13±8.84

7.60±7.3*

12.7±8.4

13.2±9.8†

Charlson Comorbidity Index Score

3.75±1.60

3.54±1.5

3.89±1.7

3.80±1.6

56.1

61.5

52.2

54.4

Heart Failure Etiology
Ischemic
Idiopathic

17.4

12.3

20.9

19.3

Other (known)

26.4

26.2

26.9

26.3

34.73±15.34

35.1 ±14.8

34.7±15.3

34.4±16.2

Class I

4.8

9.5*

4.5

0†

Class II

34.9

54*

32.8

16.1†

Class III

47.3

31.7*

44.8

67.9†

Class IV

12.9

4.8*

17.9

16.1†

85.0

80

70.6

73.3

Left Ventricular Ejection Fraction
New York Heart Association Class

Heart Failure Medications
ACE inhibitor or ARB
β-adrenergic blocker

85.0

86.2

79.4

90

MLHFQ Score

41.10±25.55

25.5±20.4*

46.5±24.6

51.7±23.9†

Duke Activity Status Index score

14.56±13.44

21.0±15.3*

13.0±11.9

9.3±9.9†

MOS Specific Adherence Score

25.30±07.25

25.7±7.7

23.6±6.6

27.3±7.0†

SCHFI Maintenance Scale Score

63.63±17.07

66.2±17.6

57.3±16.5

68.3±15.0†

SCHFI Confidence Scale Score

67.69±15.31

71.8±14.3*

62.0±14.2

70.0±15.8†

47.6±12.1

81.2±10.1

SCHFI Management Scale Score
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Table 3

Self-Care Management and Event Risk: Cox Proportional Hazard Model
Results shown controlling for the influence of gender, body mass index, comorbid conditions, HF etiology,
left ventricular ejection fraction, New York Heart Association functional class, prescription of an ACE
inhibitor or ARB, Minnesota Living with Heart Failure Questionnaire score, Medical Outcomes Study
Specific Adherence Score, and SCHFI maintenance and confidence subscale scores. “*” P<.05, “†” relative to
persons with SCHFI Self-Care Management scores below the sample mean. Abbreviations: ACE =
angiotensin converting enzyme, ARB = angiotensin receptor blocker, CI = confidence interval, HR = Hazard
Ratio, SCHFI = Self-Care of Heart Failure Index.
Variable

Adjusted HR

95%CI of HR

Age in years

0.967*

(0.941-0.995)

Beck Depression Inventory II score

1.074*

(1.038-1.111)

Prescribed Beta adrenergic blocker

0.346*

(0.187-0.641)

Duke Activity Status Index Score

0.960*

(0.930-0.991)

Symptom-Free †

0.481*

(0.238-0.971)

Above Average Self-Care Management Score †

0.441*

(0.222-0.877)
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